The gut in critical illness: Evidence from human studies

Shock

Volumn 6, Issue 6 SUPPL., 1996, Pages

  Marshall, John C ^a   Nathens, Avery B ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BACTERIAL INFECTION; CRITICAL ILLNESS; CROSS INFECTION; DIGESTIVE FUNCTION; DIGESTIVE SYSTEM; HUMAN; INTENSIVE CARE UNIT; MICROBIOLOGY; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; SEPSIS; TREATMENT OUTCOME;

ANIMALS; BACTERIAL INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; DIGESTIVE PHYSIOLOGY; DIGESTIVE SYSTEM; HUMANS; INTENSIVE CARE UNITS; MORBIDITY; POSTOPERATIVE COMPLICATIONS; SEPSIS; TREATMENT OUTCOME;

EID: 0029680964     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199610001-00004     Document Type: Article

References (92)

1. Majno G: The ancient riddle of Sepsis. J Inf Dis 163:937-945, 1991.
2. Metchnikoff E: The Wilde Medal and Lecture of the Manchester Literary and Philosophical Society. Br Med J 1:1027-1028, 1901.
3. Bibel DJ: Elie Metchnikoff s bacillus of long life. ASM News 54:661-665, 1988.
4. Lane WA: Chronic Intestinal stasis. Br Med J 1:989-993, 1912.
5. Schweinburg FB, Sendo F, Fine J: Transmural migration of intestinal bacteria: A study based on the use of radioactive E. coli. N Engl J Med 242:747-751, 1950.
6. Ravin HA, Rowley D, Jenkins C, Fine J: On the absorption of bacterial endotoxin from the gastrointestinal tract of the normal and shocked animal. J Exp Med 112:783-792, 1960.
7. Fine J, Frank ED, Ravin HA, Rutenberg SH, Schweinburg FB: The bacterial factor in traumatic shock. N Engl J Med 260:214-220, 1959.
8. Cuevas P, Ishiyama M, Koizumi S, Woodruff P, Kaufman A, Fine J: Role of endotoxemia of intestinal origin in early death from large burns. Surg Gynecol Obstet 138:725-730, 1974.
9. Rutenburg AM, Sonnenblick E, Roven I, Aprahamian HA, Reiner L, Fine J: The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 106:1-19, 1957.
10. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple organ failure syndrome: The gastrointestinal tract: The 'motor' of MOF. Arch Surg 121:196-208, 1986.
11. Wilmore DW, Smith RJ, O'Dwyer ST, Jacobs DO, Ziegler TR, Wang XD: The gut: A central organ after surgical stress. Surgery 104:917-923, 1988.
12. Deitch EA: The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125:403-404, 1990.
13. Sori AJ, Rush BF, Lysz TW, Smith S, Machiedo GW: The gut as source of sepsis after hemorrhagic shock. Am J Surg 155:187-192, 1988.
14. Wells CL, Maddaus MA, Simmons RL: Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10:958-979, 1988.
15. Maejima K, Deitch E, Berg RD: Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injury. Infect Immun 43:6-10, 1984.
16. Marshall JC, Christou NV, Meakins JL: Small bowel bacterial overgrowth and systemic immunosuppression in experimental peritonitis. Surgery 104:404-411, 1988.
17. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH: Evidence favoring the role of the gut as a cytokine generating organ in rats subjected to hemorrhagic shock. Shock 1:141-146, 1994.
18. Deitch EA, Xu D, Qi L, Berg RD: Bacterial translocation from the gut impairs systemic immunity. Surgery 109:269-276, 1991.
19. Nolan JP, Leibowitz AI: Liver physiology and Disease: Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin B an antiendotoxin. Gastroenterology 75:445-449, 1978.
20. Van Den Broek MF, Van bruggen MCJ, Koopman JP, Hazenberg MP: Gut flora induces and maintains resistance against streptococcal cell wall induced arthritis in F344 rats. Clin Exp Immunol 88:313-317, 1992.
21. Penhale WJ, Young PR: The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin exp Immunol 72:288-292, 1988.
22. Evans WE, Darin JC: Effect of enterectomy in endotoxin shock. Surgery 60:1026-1029, 1966.
23. Du Moulin GC, Hedley-Whyte J, Paterson DG, Lisbon A: Aspiration of gastric bacteria in antacid reated patients: A frequent cause of postoperative colonisation of the airway. Lancet 1:242-245, 1982.
24. Marshall JC, Christou NV, Horn R, Meakins JL: The microbiology of multiple organ failure: The proximal GI tract as an occult reservoir of pathogens. Arch Surg 123:309-315, 1988.
25. Ding JW, Andersson R, Soltesz V, Will'n R, Bengmark S: Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res 57:238-245, 1994.
26. Nathens AB, Rotstein OD, Dackiw A, Marshall JC: Intestinal epithelial cells downregulate macrophage TNF production: A mechanism for immune regulation in the gut-associated lymphoid tissues. Surgery 118:343-351, 1995.
27. Kim FJ, Moore EE, Moore FA, Biffl WL, Fontes B, Banerjee A: Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res 58:636-640, 1995.
28. Gorbach SL, Plaut AG, Nahas L, Weinstein L, Spaknebel G, Levitan R: Studies of intestinal microflora. II. Micro organisms of the small intestine and their relations to oral and fecal flora. Gastroenterology 53:856-867, 1967.
29. Savage DC: Microbial ecology of the gastrointestinal tract. Annu Rev Med 31:107-133, 1977.
30. Michie HR, Spriggs DR, Manogue KR, et al: Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104:280-286, 1988.
31. Taveira Da Silva AM, Kaulach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL: Brief report: shock and multiple organ dysfunction after self administration of salmonella endotoxin. N Engl J Med 328:1457-1460, 1993.
32. Gorbach SL, Nahas L, Lerner PI, Weinstein L: Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 53:845-855, 1967.
33. Bode JC, Bode C, Heidelbach R, Durr H-K, Martini GA: Jejunal microflora in patients with chronic alcoholic abuse. Hepato-gastroenterol 31: 30-34, 1984.
34. Stockbrugger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ, Walters CL: Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 23:1048-1054, 1982.
35. Greenlee HB, Vivit R, Paez J, Dietz A: Bacterial flora of the jejunum following peptic ulcer surgery. Arch Surg 102:260-265, 1971.
36. Roscher R, Oettinger W, Beger HG: Bacterial microflora, endogenous endotoxin, and prostaglandins in small bowel obstruction. Am J Surg 155:348-355, 1988.
37. Hillman KM, Riordan T, O'Farrell SM, Tabaqchali S: Colonization of the gastric contents in critically ill patients. Crit Care Med 10:444-447, 1982.
38. Garvey BM, McCambley JA, Tuxen DV: Effects of gastric alkalization on bacterial colonization in critically ill patients. Crit Care Med 17:211-216, 1989.
39. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract: The "undrained abscess" of multiple organ failure. Ann Surg 218:111-119, 1993.
40. Ryan CM, Yarmush ML, Burke JF, Tompkins RG: Increased gut permeability early after burns correlates with the extent of bum injury. Crit Care Med 20:1508-1512, 1992.
41. Roumen RMH, Hendriks T, Wevers RA, Goris RJA: Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 128:453-457, 1993.
42. Langkamp-Henken B, Donovan TB, Pate LM, Maull CD, Kudsk KA: Increased intestinal permeability following blunt and penetrating trauma. Crit Care Med 23:660-664, 1995.
43. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW: Increased intestinal permeability associated with infection in burn patients. Arch Surg 123:1313-1319, 1988.
44. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW: Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Resp Crit Care Med 152:1545-1548, 1995.
45. Winchurch RA, Thupari JN, Munster AM: Endotoxemia in burn patients: Levels of circulating endotoxins are related to burn size. Surgery 102: 808-812, 1987.
46. Andersen LW, Landow L, Baek L, Jansen E, Baker S: Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210-217, 1993.
47. Bounous G: Acute necrosis of the intestinal mucosa. Gastroenterology 82:1457-1467, 1982.
48. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W: Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized trial in 75 critically ill patients. N Engl J Med 302:424-430, 1980.
49. Cook DJ, Fuller H, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330:377-381, 1994.
50. Doglio DR, Pusajo JF, Egurrola MA, et al: Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 19:1037-1040, 1991.
51. Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339:195-199, 1992.
52. Fiddian-Green RG, McGough E, Pittenger G, Rothman E: Predictive value of of intramural pH and other risk factors for massive bleeding from stress ulceration. Gastroenterology 85:613, 1983.
53. Garrison RN, Fry DE, Berberich S, Polk HC: Enterococcal bacteremia: Clinical implications and determinants of death. Ann Surg 196:43-47, 1982.
54. Dyess DL, Garrison RN, Fry DE: Candida sepsis. Implications of polymicrobial blood borne infection. Arch Surg 120:345-348, 1985.
55. Fiddian-Green RG, Gantz NM: Transient episodes of sigmoid ischemia and their relation to infection from intestinal organisms after abdominal aortic operations. Crit Care Med 15:835-839, 1987.
56. Gaussorgues Ph, Gueugniaud PY, Vedrinne JM, Salord F, Mercatello A, Robert D: Septicemies dans les suites immediates des arrets cardiocirculatoires. Rean Soins Intens Med Urg 2:67-69, 1986.
57. LeFrock JL, Ellis CA, Turchik JB, Weinstein L: Transient bacteremia associated with sigmoidoscopy. N Engl J Med 289:467-469, 1973.
58. Levy J, Van Laethem Y, Verhaegen G, Perpete C, Butzler JP, Wenzel RP: Contaminated enteral nutrition solutions as a cause of nosocomial bloodstream infection: A study using plasmid fingerprinting. JPEN 13:228-234, 1989.
59. Krause W, Matheis H, Wulf K: Fungaemia and funguria after oral administration of Candida albicans. Lancet 1:598-599, 1969.
60. Heyland D, Mandell LA: Gastric colonization by Gram-negative bacilli and nosocomial pneumonia in the intensive care unit patient: Evidence for causation. Chest 101:187-193, 1992.
61. Stoutenbeek CP, van Saene HKF, Miranda DR, Zandstra DF, Binnendijk B: The prevention of superinfection in multiple trauma patients. J Antimicrob Chemotherap 14 Suppl.:203-211, 1984.
62. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group: Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Br Med J 307:525-532, 1993.
63. Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee HN, Guyatt GH: Selective decontamination of the digestive tract: An overview. Chest 105:1221-1229, 1994.
64. Kollef MH: The role of selective digestive tract decontamination on mortality and respirtaory tract infections: A meta-analysis. Chest 105: 1101-1108, 1994.
65. Nathens AB, Marshall JC: Selective decontamination of the digestive tract (SDD) in surgical patients. Submitted for publication.
66. Driks MR, Craven DE, Celli BR, et al: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: The role of gastric colonization. N Engl J Med 317:1376-1382, 1987.
67. Giannella RA, Broitman SA, Zamcheck N: Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 13:251-256, 1972.
68. Cook DJ, Laine LA, Guyatt GH, Raffin TA: Nosocomial pneumonia and the role of gastric pH: A meta-analysis. Chest 100:7-13, 1991.
69. Kudsk KA, Croce MA, Fabian TC, et al: Enteral versus parenteral feeding: Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 215:503-513, 1992.
70. Moore FA, Feliciano DV, Andrassy RJ, et al: Early enteral feeding, compared with parenteral, reduces postoperative septic complications: The results of a meta-analysis. Ann Surg 216:172-183, 1992.
71. Heyland D, Bradley C, Mandell LA: Effect of acidified enteral feedings on gastric colonization in the critically ill patient. Crit Care Med 20:1388-1394, 1992.
72. Petros AJ, Marshall JC, van Saene HKF: Is mortality an appropriate endpoint for clinical trials in critical illness? Lancet 345:369-371, 1995.
73. Lau J, Antman EM, Jimenez-Silva J: Cumulative meta-analyses of therapeutic trials for myocardial infarction. N Engl J Med 327:248, 1992.
74. Collins R, Schrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 318:1162-1173, 1988.
75. Marshall JC, Christou NV, Meakins JL: Immunomodulation by altered gastrointestinal tract flora: The effects of orally administered, killed Staphylococcus epidermidis, Candida, and Pseudomonas on systemic immune responses. Arch Surg 123:1465-1469, 1988.
76. Marshall JC, Ribeiro MB, Chu PTY, Rotstein OD, Sheiner PA: Portal endotoxemia stimulates the release of an immunosuppressive factor from alveolar and splenic macrophages. J Surg Res 55:14-20, 1993.
77. Arita H, Ogle CK, Alexander JW, Warden GD: Induction of hypermetabolism in guinea pigs by endotoxin infused through the portal vein. Arch Surg 123:1420-1424, 1988.
78. Fong Y, Marano MA, Moldawer LL, et al: The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904, 1990.
79. Fong Y, Marano MA, Barber A, et al: Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 210:449, 1989.
80. Bender BS, Winchurch RA, Thupari JN, Proust JJ, Adler WH, Munster AM: Depressed natural killer cell function in thermally injured adults: Successful in vivo and in vitro immunomodulation and the role of endotoxin. Clin exp Immunol 71:120-125, 1988.
81. Roland CR, Goss JA, Mangino MJ, Hafenrichter D, Flye MW: Autoregulation by eicosanoids of human Kupffer cell secretory products: A study of interleukin-1, interleukin-6, tumor necrosis factor-α, transforming growth factor-β, and nitric oxide. Ann Surg 219:389-399, 1994.
82. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute phase response of human hepatocytes: Regulation of acule phase protein synthesis by interleukin 6. Hepatology 12:1179-1186, 1990.
83. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW: Antiinflammatory properties of heptic acute phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J Exp Med 178:1629-1636, 1993.
84. Moore FA, Moore EE, Poggetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 31:629-638, 1991.
85. Reusser P, Zimmerli W, Scheidegger D, Marbet G, Buser M, Gyr K: Role of gastric colonization in nosocomial infections and endotoxemia: A prospective study in neurosurgical patients on mechanical ventilation. J Inf Dis 160:414-421, 1989.
86. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S: A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 326:594-599, 1992.
87. Simms HH, DeMaria E, McDonald L, Peterson D, Robinson A, Burchard KW: Role of gastric colonization in the development of pneumonia in critically ill trauma patients: Results of a prospective randomized trial. J Trauma 31:531-537, 1991.
88. Leu H-S, Kaiser DL, Mori M, et al: Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129:1258, 1989.
89. Rello J, Ausina V, Ricart M, Castella J, Prats G: Impact of previous antimicrobial therapy on the etiology and outcome of ventilator associated pneumonia. Chest 104:1230-1235, 1993.
90. Poole GV, Muakkassa FF, Griswold JA: Pneumonia, selective decontamination, and multiple organ failure. Surgery 111:1-3, 1992.
91. Marshall JC, Sweeney D: Microbial infection and the septic response in critical surgical illness: Sepsis, not infection, determines outcome. Arch Surg 125:17-23, 1990.
92. Fink MP: Another negative clinical trial of a new agent for the treatment of sepsis: Rethinking the process of developing adjuvant treatments for serious infections. Crit Care Med 23:989-991, 1995.